tiprankstipranks
Biotricity Inc (BTCY)
NASDAQ:BTCY
US Market

Biotricity Stock Analysis & Ratings

BTCY Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.95 - $5.30
Previous Close$1.6
Volume55.46K
Average Volume (3M)120.42K
Market CapN/A
Enterprise ValueN/A
P/E Ratio-2.3
Beta1.21
Next EarningsAug 29, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price TargetN/A
Smart Score3


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

BTCY FAQ

What was Biotricity’s price range in the past 12 months?
Biotricity lowest stock price was $0.95 and its highest was $5.30 in the past 12 months.
    What is Biotricity’s market cap?
    Currently, no data Available
    What is Biotricity’s price target?
    Currently, no data Available
    What do analysts say about Biotricity?
    Not enough analysts have published a price target to provide an average price target.
    When is Biotricity’s upcoming earnings report date?
    Biotricity’s upcoming earnings report date is Aug 29, 2022 which is in 54 days.
      How were Biotricity’s earnings last quarter?
      Biotricity released its earnings results on Feb 14, 2022. The company reported -$0.149 earnings per share for the quarter, missing the consensus estimate of -$0.137 by -$0.012.
        Is Biotricity overvalued?
        According to Wall Street analysts Biotricity’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Biotricity pay dividends?
          Biotricity does not currently pay dividends.
          What is Biotricity’s EPS estimate?
          Biotricity’s EPS estimate is -$0.12.
            How many shares outstanding does Biotricity have?
            Biotricity has 49,927,048 shares outstanding.
              What happened to Biotricity’s price movement after its last earnings report?
              Biotricity reported an EPS of -$0.149 in its last earnings report, missing expectations of -$0.137. Following the earnings report the stock price went down -1.333%.
                Which hedge fund is a major shareholder of Biotricity?
                Currently, no hedge funds are holding shares in BTCY

                ---

                Biotricity Stock Analysis

                Smart Score
                3
                Underperform
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10
                Price Target
                No data currently available
                The Biotricity stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                Learn more about TipRanks Smart Score

                Company Description

                Biotricity Inc

                Biotricity, Inc. engages in the provision of biometric data monitoring solutions. The firm offers the Bioflux, a single-unit mobile cardiac telemetry device. It also develops Biolife, which is intended for chronic disease prevention. The company was founded by Waqaas Al-Siddiq and Peter McGoldrick on August 29, 2012 and is headquartered in Redwood City, CA.

                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                MGT Capital Investments
                Future FinTech Group
                US Nuclear
                Marathon Digital Holdings
                Longfin

                Popular Stocks

                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis